The prevalence of clinically relevant herb-drug interactions between herbal products and anti-cancer therapy in older adults with cancer – A cross-sectional study
Potentially relevant HDIs between herbal supplements and oncological treatment occur in 4 % of older adults with cancer and half of these are clinically relevant. Healthcare providers should question patients with cancer on the use of herbal supplements and monitor for relevant HDI with the treatment given.
Authors
- Johanneke E.A. Portielje (ORCID: https://orcid.org/0000-0002-5169-6306)
- Edwin J. Brokaar (ORCID: https://orcid.org/0000-0003-0253-9678)
- Loes E. Visser (ORCID: https://orcid.org/0000-0002-1421-6246)
- Frederiek van den Bos (ORCID: https://orcid.org/0000-0003-1426-3509)
Institutions
- Leiden University Medical Center (NL)
- Erasmus MC (NL)
- Haga Hospital (NL)
Publication Details
- Journal
- Exploratory Research in Clinical and Social Pharmacy
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1016/j.rcsop.2025.100585
- Primary Topic
- Complementary and Alternative Medicine Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00